Vaccine Buyers Get Sanofi's Antitrust Claim Scrapped

Law360, New York (December 21, 2012, 5:43 PM EST) -- The New Jersey federal judge overseeing a proposed class action claiming Sanofi Pasteur Inc. pushed anti-competitive contract restrictions onto vaccine customers tossed the drugmaker's antitrust counterclaim on Thursday, saying Sanofi hadn't supported assertions that customers colluded to demand discounts that lowered vaccine prices to noncompetitive levels.

In granting the medical practitioner plaintiffs' motion to dismiss the counterclaim, U.S. District Judge Jose L. Linares said Sanofi hadn't alleged facts to support the plausible inference that the physician buying groups that entered agreements with the drugmaker to buy...
To view the full article, register now.